Volume 8, Number 11—November 2002
THEME ISSUE
Tuberculosis Genotyping
Tuberculosis Genotyping Network, United States
Estimated Costs of False Laboratory Diagnoses of Tuberculosis in Three Patients
Table 1
Cost inventory for three patients who received misdiagnoses of active tuberculosis disease on the basis of laboratory cross-contamination of Mycobacterium tuberculosis specimensa
Patient | Public sectorb | Private sectorc |
---|---|---|
Direct medical costs | ||
TB medications | Outpatient visits TB medications and PPD DOT provision Tests and procedures Contact investigations Hospitalizations | Outpatient visits TB medications and PPD Tests and procedures Contact investigations Hospitalizations |
Direct nonmedical costs | ||
Case managementd Overheade |
aTB, tuberculosis; PPD, purified protein derivative of tuberculin; DOT, directly observed therapy.
bLocal and state public health departments, public health hospital and laboratory, and county and state correctional facilities.
cPrivate physicians, hospitals, and laboratories.
dHealth department case management and administrative support.
eOverhead costs, including rent, utilities, and supplies.